Cymra’s Genetic Licensing Program allows cultivators to access our premium field tested genetics to
reduce risks of diseases
provide higher % of chemical compounds desired
The Biotechnology Agreement will contain terms for licensing of intellectual property developed by us.
Vir Pharma will have an ongoing breeding program and regularly release new varieties which will be offered on a licensing and royalty program. Vir Pharma’s intention is that the new varieties will have improved desirable characteristics such as disease resistance, increased yield, increased agronomic efficiencies.